Biotech Stocks Set For More Pain After Worst April In Decades

Skip to content Bloomberg the Company & Its ProductsThe Company & its ProductsBloomberg Terminal Demo RequestBloomberg Anywhere Remote LoginBloomberg Anywhere LoginBloomberg Customer SupportCustomer Support

• Bloomberg

  Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world

  For Customers

  • Bloomberg Anywhere Remote Login
  • Software Updates
  • Manage Products and Account Information

  Support

  Americas+1 212 318 2000

  EMEA+44 20 7330 7500

  Asia Pacific+65 6212 1000

• Company

  • About
  • Careers
  • Inclusion at Bloomberg
  • Tech at Bloomberg
  • Philanthropy
  • Sustainability
  • Bloomberg Beta

  Communications

  • Press Announcements
  • Press Contacts

  Follow

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube

• Products

  • Bloomberg Professional Services
  • Bloomberg Terminal
  • Data
  • Trading
  • Risk
  • Compliance
  • Indices

  Industry Products

  • Bloomberg Law
  • Bloomberg Tax
  • Bloomberg Government
  • BloombergNEF

• Media

  • Bloomberg Markets
  • Bloomberg Technology
  • Bloomberg Pursuits
  • Bloomberg Politics
  • Bloomberg Opinion
  • Bloomberg Businessweek
  • Bloomberg Live Conferences
  • Bloomberg Radio
  • Bloomberg Television
  • News Bureaus

  Media Services

  • Bloomberg Media Distribution
  • Advertising

• Company

  • About
  • Careers
  • Inclusion at Bloomberg
  • Tech at Bloomberg
  • Philanthropy
  • Sustainability
  • Bloomberg Beta

  Communications

  • Press Announcements
  • Press Contacts

  Follow

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube

• Products

  • Bloomberg Professional Services
  • Bloomberg Terminal
  • Data
  • Trading
  • Risk
  • Compliance
  • Indices

  Industry Products

  • Bloomberg Law
  • Bloomberg Tax
  • Bloomberg Government
  • BloombergNEF

• Media

  • Bloomberg Markets
  • Bloomberg Technology
  • Bloomberg Pursuits
  • Bloomberg Politics
  • Bloomberg Opinion
  • Bloomberg Businessweek
  • Bloomberg Live Conferences
  • Bloomberg Radio
  • Bloomberg Television
  • News Bureaus

  Media Services

  • Bloomberg Media Distribution
  • Advertising

• Bloomberg

  Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world

  For Customers

  • Bloomberg Anywhere Remote Login
  • Software Updates
  • Manage Contracts and Orders

  Support

  Americas+1 212 318 2000

  EMEA+44 20 7330 7500

  Asia Pacific+65 6212 1000

Sign InSubscribeSearchLive TV

• MarketsChevron Down
• Economics
• Industries
• Tech
• Politics
• Businessweek
• Opinion
• MoreChevron Down

US EditionChevron DownMenuSubscribeMarketsFacebookXLinkedInEmailLinkGift

FacebookXLinkedInEmailLinkGiftGift this articleContact us:Provide news feedback or report an errorConfidential tip?Send a tip to our reportersSite feedback:Take our SurveyNew WindowFacebookXLinkedInEmailLinkGiftBy Cristin FlanaganApril 29, 2022 at 4:29 PM UTCUpdated on April 29, 2022 at 8:09 PM UTCBookmarkSaveLock This article is for subscribers only.

Biotechnology stocks are facing the grimmest April on record amid regulatory concerns and the market shift to safer bets. Some are even comparing it to the 2000 tech crash, with the worst yet to come.

Biotech stocks in the Russell 2000 closed out their worst April since at least 1997, when Bloomberg started tracking returns. The sector has tumbled roughly 65% from its February 2021 peak, sinking 22% in April alone.

HomeBTV+Market DataOpinionAudioOriginalsMagazineEventsNewsMarketsEconomicsTechnologyPoliticsGreenCryptoAIWork & LifeWealthPursuitsBusinessweekCityLabSportsEqualityManagement & WorkMarket DataStocksCommoditiesRates & BondsCurrenciesFuturesSectorsEconomic CalendarExploreNewslettersExplainersPointed News QuizAlphadots GameThe Big TakeGraphicsSubmit a TipAbout UsTerms of ServiceDo Not Sell or Share My Personal InformationTrademarksPrivacy PolicyCareersAdvertiseAd ChoicesHelp©2026 Bloomberg L.P. All Rights Reserved.